Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BTG to commercialise sleep disorder sensor:

This article was originally published in Clinica

Executive Summary

The international subsidiary of UK technology transfer company BTG is looking for a partner to commercialise a non-invasive monitor for respiratory disorders such as sleep apnoea and sudden infant death syndrome (SIDS). The monitor uses a fibre-optic coupler sensor which is placed on a person's pulse point. This allows a single sensor to detect heartbeat and respiration rate at the same time. A second sensor can be used to monitor blood pressure. To detect SIDS a single fibre-optic cable could be incorporated into a thin mattress, says BTG. Unlike most infant apnoea monitors, it would not need to be connected to the baby. Software associated with the sensor can identify changes in breathing while eliminating the effects of body movements.

You may also be interested in...

US FDA Pharmaceutical Quality Office Lauds Continuous Manufacturing Approvals

The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.

Warning Letter Roundup & Recap – 19 February 2020

No device-related warning letters were released by the US FDA the week of 19 February.

Harmonization Needed For Complex And Value-Added Drugs

Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts